Anderson KC - Search Results

1

Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial.

Holstein SA, Jung SH, Richardson PG, Hofmeister CC, Hurd DD, Hassoun H, Giralt S, Stadtmauer EA, Weisdorf DJ, Vij R, Moreb JS, Callander NS, van Besien K, Gentile TG, Isola L, Maziarz RT, Bashey A, Landau H, Martin T, Qazilbash MH, Rodriguez C, McClune B, Schlossman RL, Smith SE, Hars V, Owzar K, Jiang C, Boyd M, Schultz C, Wilson M, Hari P, Pasquini MC, Horowitz MM, Shea TC, Devine SM, Linker C, Anderson KC, McCarthy PL. Holstein SA, et al. Among authors: anderson kc. Lancet Haematol. 2017 Sep;4(9):e431-e442. doi: 10.1016/S2352-3026(17)30140-0. Epub 2017 Aug 17. Lancet Haematol. 2017. PMID: 28826616 Free PMC article. Clinical Trial.

2

Tumor Cell Expression of CD59 Is Associated With Resistance to CD20 Serotherapy in Patients With B-Cell Malignancies.

Treon SP, Mitsiades C, Mitsiades N, Young G, Doss D, Schlossman R, Anderson KC. Treon SP, et al. Among authors: anderson kc. J Immunother (1991). 2001 May;24(3):263-271. J Immunother (1991). 2001. PMID: 11395643

3

Identification of genes regulated by dexamethasone in multiple myeloma cells using oligonucleotide arrays.

Chauhan D, Auclair D, Robinson EK, Hideshima T, Li G, Podar K, Gupta D, Richardson P, Schlossman RL, Krett N, Chen LB, Munshi NC, Anderson KC. Chauhan D, et al. Among authors: anderson kc. Oncogene. 2002 Feb 21;21(9):1346-58. doi: 10.1038/sj.onc.1205205. Oncogene. 2002. PMID: 11857078

4

Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications.

Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Richardson PG, Hideshima T, Munshi N, Treon SP, Anderson KC. Mitsiades N, et al. Among authors: anderson kc. Blood. 2002 Jun 1;99(11):4079-86. doi: 10.1182/blood.v99.11.4079. Blood. 2002. PMID: 12010810 Free article.

5

Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications.

Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Richardson PG, Hideshima T, Munshi NC, Treon SP, Anderson KC. Mitsiades N, et al. Among authors: anderson kc. Blood. 2002 Jun 15;99(12):4525-30. doi: 10.1182/blood.v99.12.4525. Blood. 2002. PMID: 12036884 Free article.

6

Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma.

Bellucci R, Alyea EP, Weller E, Chillemi A, Hochberg E, Wu CJ, Canning C, Schlossman R, Soiffer RJ, Anderson KC, Ritz J. Bellucci R, et al. Among authors: anderson kc. Blood. 2002 Jun 15;99(12):4610-7. doi: 10.1182/blood.v99.12.4610. Blood. 2002. PMID: 12036895 Free article.

7

Cytokines modulate telomerase activity in a human multiple myeloma cell line.

Akiyama M, Hideshima T, Hayashi T, Tai YT, Mitsiades CS, Mitsiades N, Chauhan D, Richardson P, Munshi NC, Anderson KC. Akiyama M, et al. Among authors: anderson kc. Cancer Res. 2002 Jul 1;62(13):3876-82. Cancer Res. 2002. Retraction in: Cancer Res. 2024 Mar 15;84(6):940. doi: 10.1158/0008-5472.CAN-24-0516. PMID: 12097303 Retracted.

8

Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications.

Mitsiades CS, Mitsiades N, Poulaki V, Schlossman R, Akiyama M, Chauhan D, Hideshima T, Treon SP, Munshi NC, Richardson PG, Anderson KC. Mitsiades CS, et al. Among authors: anderson kc. Oncogene. 2002 Aug 22;21(37):5673-83. doi: 10.1038/sj.onc.1205664. Oncogene. 2002. PMID: 12173037

9

2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells.

Chauhan D, Catley L, Hideshima T, Li G, Leblanc R, Gupta D, Sattler M, Richardson P, Schlossman RL, Podar K, Weller E, Munshi N, Anderson KC. Chauhan D, et al. Among authors: anderson kc. Blood. 2002 Sep 15;100(6):2187-94. doi: 10.1182/blood-2002-02-0376. Blood. 2002. PMID: 12200384 Free article.

10

Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model.

LeBlanc R, Catley LP, Hideshima T, Lentzsch S, Mitsiades CS, Mitsiades N, Neuberg D, Goloubeva O, Pien CS, Adams J, Gupta D, Richardson PG, Munshi NC, Anderson KC. LeBlanc R, et al. Among authors: anderson kc. Cancer Res. 2002 Sep 1;62(17):4996-5000. Cancer Res. 2002. PMID: 12208752

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,206 results

Search Page